THINK
- South Africa
1. TMC207-TiDP13-C209: Study Title A Phase II, open label trial to evaluate the safety, and tolerability and efficacy of TMC207 in subjects with sputum smear-positive pulmonary infection with multi-drug resistant ...
- Size Other
- Previous clinical trials 1-5
- Staff 26